Transcatheter aortic valve implantation (TAVI) is an effective treatment option for patients suffering from symptomatic, severe aortic valve stenosis. Previously, only patients with prohibitive or high surgical risk were TAVI candidates; however, current guidelines already recommend TAVI as a treatment alternative for patients with intermediate surgical risk. Multidetector computed tomography (MDCT) has gained great importance in the periprocedural assessment of patients who undergo TAVI. Due to the three-dimensional image visualization, MDCT allows the evaluation of anatomical structures in a more comprehensive manner compared to echocardiography, the traditional tool used in TAVI patient work-up. By providing accurate measurements of the aortic root, MDCT helps to avoid potential patient-prosthesis mismatch throughout transcatheter valve sizing. Moreover, MDCT is also a feasible tool for access route evaluation and to determine the optimal projection angles for the TAVI procedure. Although the routine MDCT follow-up of patients is currently not recommended in clinical practice, if performed, it could provide invaluable information about valve integrity and asymptomatic leaflet thrombosis. Post-procedural MDCT can provide details about the position of the prosthesis and complications such as leaflet-thrombosis, aortic regurgitation, coronary occlusion, and other vascular complications that can represent major cardiac emergencies. The aim of the current review is to overview the role of MDCT in the pre-and post-procedural assessment of TAVI patients. In the first part, the article presents the role of pre-TAVI imaging in the complex anatomical assessment of the aortic valve and the selection of the most appropriate device. The second part of the review describes the role of MDCT in patients who underwent TAVI to assess potential complications, some of them leading to a major cardiovascular emergency.
INTRODUCTION
examinations should be performed with the use of iodinated contrast medium in order to achieve better visualization of vascular and cardiac structures. Special attention should be paid to minimize the amount of injected contrast medium, as the majority of the examined population comprises predominantly elderly patients with a considerable number of comorbidities such as impaired renal function. As low as 30 mL of iodinated contrast medium can already be sufficient to properly visualize the aortic root and the iliofemoral vasculature. 6 A flow of 3 mL/s (in contrast with the 5-6 mL/s usually used for coronary imaging) is, in most cases, feasible for the pre-TAVI imaging.
DIAGNOSIS OF AORTIC STENOSIS AND VALVE MORPHOLOGY ASSESSMENT
Although in current clinical practice, echocardiography is the gold standard in the evaluation of valve morphology and AS severity, MDCT seems to be a reliable alternative.
Calcium scoring of the aortic valve has gained importance in the preoperative assessment of AS severity, in particular among patients with low-flow, low-gradient AS with preserved ejection fraction. 7 Moreover, MDCT images could be used to derive the aortic valve area needed for the detection of AS, with similar accuracy to transesophageal echocardiography (TEE). Currently, however, these measurements are not primer indications of MDCT prior to TAVI.
MEASUREMENT OF AORTIC ANNULUS, AORTIC ROOT, ASCENDING AORTA
TAVI valve size selection is a complex decision, and various factors must be taken into account. Examining the exact FIGURE 1. Contrast-enhanced MDCT images of annular calcification (white arrow) and severe AS with moderate calcification of all three cusps. A cross-sectional image of the aortic valve is seen in the bottom right corner, demonstrating thickened cusps.
anatomy of the aortic root is an important step in choosing the appropriate valve size and minimizing paravalvular leakage (PVL) and other complications ( Figure 1) . A virtual basal ring is used for prosthesis sizing. 8 The basal ring is a crown-like structure, where the prosthetic valve anchors.
It is the ring that crosses the insertion points of each cusp. 9 Good contact must be achieved here in order to prevent PVL. Therefore, the three-dimensional examination of the basal ring is of high importance ( Figure 2 ). Due to its spatial resolution and high reproducibility, MDCT is a useful tool for this purpose. Ciobotaru et al. came to the conclusion that the decision concerning prosthesis size would have been changed in 32% of the cases if three-dimensional annulus sizing were applied. 10 However, we have to keep in mind that the basal ring is only a virtual approximation of the anatomic aortic annulus (AA), with limitations. During the cardiac cycle, more than half of the aortic circumference moves -e.g., during diastole, the aortic annulus is more ovoid-shaped. 10 These changes can lead to a weaker contact between the annulus and the prosthesis.
Thus, basal ring MDCT measurements underestimate the real aortic annulus area, and the three-dimensional oversizing index ([transcatheter heart valve area / 3D-AA area -1] × 100) proved to be the most predictive independent factor for PVL.
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The pre-procedural assessment of patients is not limited to the evaluation of the aortic annulus; complete anatomic characterization of the aortic root and the ascending aorta is required. These measurements should provide information about the dimensions of the leaflets, the aortic sinus, the sinotubular junction, and the ascending aorta as well. Additionally, it is essential to describe the distance of the coronary ostia to the aortic valve plane in order to prevent potentially fatal complications such as post-procedural coronary occlusion ( Figure 3 ).
Imaging of the aorta and peripheral vessels should extend from the aortic arch (and potentially the subclavian artery) to below the groin, including the aorta, and the iliac and femoral arteries.
ECG-synchronization is required for imaging of the aortic root: the use of either retrospective or prospective gating depends on patient characteristics and scanner capabilities.
Most institutions, however, prefer retrospective gating, considering the higher incidence of arrhythmias. Another important aspect in favor of retrospective gating is that the largest dimensions of the annulus are observed in systole, which should be covered entirely during data acquisition.
The inherently higher radiation dose can be acceptable considering the higher age of the patient population. 
CALCIFICATION
The calcification of all regions of the aortic valve complex can predict post-procedural PVL. Bulky calcifications of the commissures might prevent complete apposition between the prosthesis and the AA leading to gaps and regurgitant jets. 11 Valve calcium volume and left ventricular outflow tract calcium are independent predictors of PVL. 12 Furthermore, recent studies suggest a potential association between aortic valve calcification and prosthesis dislodgement, and severe calcification could result in obstruction of the coronary ostia during TAVI. 13, 14 Therefore, description of the extent and severity of aortic calcification is recommended. In Figure 4 we can see various degrees of aortic valve calcification.
IMAGING OF ACCESS ROUTES
MDCT imaging is also the method of choice for the evalu- artery diameters compared to external sheath diameters. 15 The presence of these risk factors can be depicted by MDCT, thus allowing for the selection of the most appropriate access route ( Figure 5 ). It is also essential to report the minimal artery diameter along the iliofemoral vascu- These measurements enable significant intraprocedural dose and contrast reduction and facilitate the appropriate implantation of the prosthesis.
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OTHER FINDINGS
The assessment of the atria and ventricles is also necessary in order to exclude the presence of a thrombus, as it could potentially be a source of embolic complications.
Furthermore, the assessment of other concomitant cardiac diseases is also feasible with MDCT. It is particularly important for pre-procedural planning to describe the severity of left ventricular hypertrophy, the angle between the aorta and the left ventricle, or a subclinical obstruction which can hinder femoral and subclavian access.
Moreover, other findings such as tumors or anomalies can also be seen on MDCT images, which can potentially have therapeutic consequences. 
POST-TAVI IMAGING
LEAFLET THROMBOSIS, REDUCED LEAFLET MOTION, HYPOATTENUATED LEAFLET THICKENING, HYPOATTENUATION AFFECTING MOTION
TAVI prosthetic valves, like all foreign bodies in the cardiovascular system, are thrombogenic. Hypo-attenuated leaflet thickening (HALT) is an MDCT diagnosis, and it is considered to be the hallmark of leaflet thrombosis.
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The prevalence of HALT is approximately 10%. 18 On contrast-enhanced MDCT images, HALT can be seen both in systole and diastole as a semilunar or wedge-shaped lowdensity structure involving the base of the TAVI leaflet and extending towards the center of the frame (Figure 7 .)
For the conclusive visualization of HALT, we have to use ideally 100 mL, but at least 50 mL of contrast agent, full retrospective gating with submillimeter slice thickness, and 120-140 kV tube voltage without dose modulation. Heart rate should be kept below 70 beats per minute. 19 HALT has to be scanned in the diastolic phase together with leaflet coaptation. For the measurement of HALT, we can use either the maximal thickness of the leaflet, the maximal area of HALT, or the volume of HALT. 19 Since where 1,000 patients with early bioprosthetic valve thrombosis will be treated with OAC for 3 months and resolution will be assessed using MDCT. These prospective studies will introduce high-quality evidence regarding the incidence of subclinical thrombosis and the optimal antithrombotic therapy for the subsequent subacute period.
The results of these studies may provide data supporting a possible change in current recommendations and practice patterns, and may lead to a larger end-point trial of major adverse cardiovascular events.
Since TAVI frame depth and stent canting can cause non-laminar flow, these factors can significantly contribute to leaflet thrombosis. Therefore, stent frame analysis is an important part of the post-TAVI follow-up. Prosthesis depth can be stratified based on the centerline-derived longitudinal distance between the base of the native aortic annulus and the prosthetic inflow (the most proximal portion of the frame): if this distance is below 4 mm, it is high, between 4 and 8 mm, it is nominal, and if the distance is above 8 mm, it represents a low implantation depth. Stent canting can be assessed with the deployed depth eccentricity index (the difference between the largest and the smallest depth).
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The first-line method for post-procedural valve assessment is TTE, which is affordable, repeatable, can easily access and assess the transaortic pressure gradient, but it cannot visualize the detailed structure of the prosthetic leaflets. 22 TEE could solve this issue; however, shadowing of the implanted valve's frame can cause difficulties sometimes, and due to its invasiveness, it cannot be a routine part of TAVI follow-up. 23 Guidelines recommend post-implantation imaging with echocardiography prior to discharge, at 6 and 12 months, then yearly. 24 However, subclinical valve thrombosis can develop within a few weeks after TAVI. In their study, Marwan et al. detected leaflet thrombosis in 23% of the enrolled patients with MDCT performed at a median of only 4 months after TAVI implantation. 25 As a consequence, the number of reported symptomatic TAVI thrombosis cases highly underestimates the exact incidence due to the suboptimal timing of follow-up imaging in TAVI patients.
POST-PROCEDURAL AORTIC REGURGITATION: PARAVALVULAR LEAKAGE AND TRANSVALVULAR REGURGITATION
Aortic regurgitation (AR) is the most frequent complication after TAVI, with an unfavorable overall 1-year mortality. 26 The overall incidence of AR after TAVI is 50 to 85%, higher than after surgical aortic valve replacement. Cardiac MDCT may allow more accurate measurements, less sizing errors, more comprehensive aortic root complex assessment, and, since it is independent from the examiner, it is more standardized. Moreover, it is also more accurate in the case of heavily calcified valves.
Transvalvular AR is less frequent than PVL and is mainly the consequence of leaflet damage, e.g. after aggressive ballooning, or due to an oversized prosthetic valve.
ATRIOVENTRICULAR CONDUCTION ABNORMALITIES
After TAVI, patients present an increased risk for atrioventricular (AV) conduction abnormalities, leading to between the AA and the coronary artery ostia is an important factor, a distance of more than 10 mm being considered safe. For the assessment of coronary artery occlusion, MDCT is a feasible method. Percutaneous coronary intervention is a safe and successful treatment in the majority of cases, without increased risk of adverse outcomes. 
